DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+5.96%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$30.1B
AUM Growth
+$3.48B
(+13%)
Cap. Flow
+$2.16B
Cap. Flow
% of AUM
7.16%
Top 10 Holdings %
Top 10 Hldgs %
23.19%
Holding
1,423
New
92
Increased
671
Reduced
310
Closed
81
Top Buys
| 1 |
Intel
INTC
|
+$115M |
| 2 |
Salesforce
CRM
|
+$95.7M |
| 3 |
Johnson & Johnson
JNJ
|
+$95M |
| 4 |
Microsoft
MSFT
|
+$89.5M |
| 5 |
Citigroup
C
|
+$77M |
Top Sells
| 1 |
CMS Energy
CMS
|
+$70.3M |
| 2 |
Amgen
AMGN
|
+$68.6M |
| 3 |
Ameren
AEE
|
+$66.6M |
| 4 |
NVIDIA
NVDA
|
+$63.6M |
| 5 |
Fidelity National Information Services
FIS
|
+$55.7M |
Sector Composition
| 1 | Technology | 24.75% |
| 2 | Healthcare | 15.88% |
| 3 | Financials | 12.34% |
| 4 | Communication Services | 9.65% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
O-I Glass
OI
$2B
| $912K | ﹤0.01% |
62,563
| – | – |
|
|
AMRN
927
Amarin Corp
AMRN
$306M
| $904K | ﹤0.01% |
7,230
| – | – |
|
928
Opko Health
OPK
$1.13B
| $893K | ﹤0.01% |
214,874
| – | – |
|
929
Greif
GEF
$3.56B
| $890K | ﹤0.01% |
15,511
| – | – |
|
930
Qualys
QLYS
$4.88B
| $875K | ﹤0.01% |
8,590
| – | – |
|
931
KB Financial Group
KB
$28.9B
| $872K | ﹤0.01% |
18,186
-7,685
| -30% | -$368K |
|
932
Schrodinger
SDGR
$1.43B
| $870K | ﹤0.01% |
+12,100
| New | +$870K |
|
|
GBT
933
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $864K | ﹤0.01% |
21,450
| – | – |
|
|
Y
934
DELISTED
Alleghany Corporation
Y
| $859K | ﹤0.01% |
1,353
+204
| +18% | +$130K |
|
|
BLUE
935
DELISTED
bluebird bio
BLUE
| $850K | ﹤0.01% |
2,287
+223
| +11% | +$82.9K |
|
936
Gold Fields
GFI
$32B
| $842K | ﹤0.01% |
93,000
-2,000
| -2% | -$18.1K |
|
|
ABST
937
DELISTED
Absolute Software Corporation Common Stock
ABST
| $838K | ﹤0.01% |
64,230
-3,057
| -5% | -$39.9K |
|
938
FibroGen
FGEN
$45.1M
| $837K | ﹤0.01% |
1,078
| – | – |
|
|
PDCE
939
DELISTED
PDC Energy, Inc.
PDCE
| $835K | ﹤0.01% |
24,500
-45,500
| -65% | -$1.55M |
|
940
Aramark
ARMK
$10.1B
| $831K | ﹤0.01% |
30,417
+4,904
| +19% | +$134K |
|
941
Varonis Systems
VRNS
$6.43B
| $829K | ﹤0.01% |
16,920
| – | – |
|
942
ScottsMiracle-Gro
SMG
$3.6B
| $826K | ﹤0.01% |
3,369
+784
| +30% | +$192K |
|
943
Apollo Global Management
APO
$76.9B
| $816K | ﹤0.01% |
17,366
+2,576
| +17% | +$121K |
|
944
Scholar Rock
SRRK
$3.04B
| $816K | ﹤0.01% |
17,100
| – | – |
|
945
Editas Medicine
EDIT
$248M
| $815K | ﹤0.01% |
19,800
| – | – |
|
|
SRCL
946
DELISTED
Stericycle Inc
SRCL
| $811K | ﹤0.01% |
12,047
| – | – |
|
947
Amicus Therapeutics
FOLD
$2.46B
| $806K | ﹤0.01% |
86,300
| – | – |
|
948
American Financial Group
AFG
$11.5B
| $792K | ﹤0.01% |
6,840
+1,102
| +19% | +$128K |
|
949
AngloGold Ashanti
AU
$31.3B
| $792K | ﹤0.01% |
36,600
-2,400
| -6% | -$51.9K |
|
950
Altice USA
ATUS
$1.05B
| $789K | ﹤0.01% |
23,984
+4,522
| +23% | +$149K |
|